Benchmark Holdings PLC
LSE:BMK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (11.9), the stock would be worth GBX15.27 (26% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 16.1 | GBX20.65 |
0%
|
| 3-Year Average | 11.9 | GBX15.27 |
-26%
|
| 5-Year Average | 12.6 | GBX16.08 |
-22%
|
| Industry Average | 0 | GBX0.01 |
-100%
|
| Country Average | 0 | GBX0.03 |
-100%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
GBX129.3m
|
/ |
Apr 2025
£8m
|
= |
|
|
GBX129.3m
|
/ |
Sep 2025
£21.9m
|
= |
|
|
GBX129.3m
|
/ |
Sep 2026
£23.9m
|
= |
|
|
GBX129.3m
|
/ |
Sep 2027
£18.2m
|
= |
|
|
GBX129.3m
|
/ |
Sep 2028
£18.6m
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
|
Benchmark Holdings PLC
LSE:BMK
|
127.1m GBP | 16.1 | 2.8 | |
| JP |
G
|
Goyo Foods Industry Co Ltd
TSE:2230
|
53.2T JPY | 186 542.5 | 540 752.8 | |
| CH |
|
Nestle SA
SIX:NESN
|
197.5B CHF | 13.3 | 21.6 | |
| US |
|
Mondelez International Inc
NASDAQ:MDLZ
|
73.4B USD | 17.9 | 29.4 | |
| FR |
|
Danone SA
PAR:BN
|
42.5B EUR | 9.6 | 23.4 | |
| ZA |
T
|
Tiger Brands Ltd
JSE:TBS
|
49.9B ZAR | 9.7 | 13.1 | |
| US |
|
Hershey Co
NYSE:HSY
|
38.8B USD | 21.2 | 43.6 | |
| CN |
|
Muyuan Foods Co Ltd
SZSE:002714
|
247.6B CNY | 15.9 | 16 | |
| CN |
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
235.3B CNY | 25.2 | 33.4 | |
| ZA |
A
|
Avi Ltd
JSE:AVI
|
33.7B ZAR | 8.9 | 13 | |
| CH |
|
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
|
24.4B CHF | 19.2 | 32.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0 |
| 70th Percentile | 0 |
| Max | 743.2 |
Other Multiples
Benchmark Holdings PLC
Glance View
Benchmark Holdings Plc engages in the provision of applied biotechnology, sustainability research, and other related services to aquaculture, agriculture, and food sector. The company is headquartered in Sheffield, South Yorkshire and currently employs 796 full-time employees. The company went IPO on 2013-12-18. The Company’s segments include Genetics, Advanced Nutrition and Health. The Genetics segment is salmon breeding technology combined with state-of-the-art production facilities to provide a range of genetic merit ova. Advanced Nutrition segment manufactures and provides nutrition and health products to the global aquaculture industry. The Health segment is focused on providing health products to the global aquaculture market. The firm has a portfolio of products and solutions, including salmon eggs with specialist genetic traits, shrimp broodstock, tilapia fry, technology enhanced live feed (Artemia), specialist diets, probiotics and sea lice treatments.
